R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma
Laribi, Kamel, Denizon, Nathalie, Bolle, Delphine, Truong, Catherine, Besançon, Anne, Sandrini, Jeremy, Anghel, Andreaa, Farhi, Jonathan, Ghnaya, Habib, Baugier de Materre, Alix
Published in Annals of hematology (01.10.2016)
Published in Annals of hematology (01.10.2016)
Get full text
Journal Article
Impact of the relative dose intensity on survival of patients with high‐risk myelodysplastic syndromes treated with Azacitidine
Laribi, Kamel, Bolle, Delphine, Alani, Mustafa, Ghnaya, Habib, Besançon, Anne, Farhi, Jonathan, Mheidly, Kayane, Denizon, Nathalie, Baugier de Materre, Alix
Published in Cancer medicine (Malden, MA) (01.05.2019)
Published in Cancer medicine (Malden, MA) (01.05.2019)
Get full text
Journal Article
Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA
Laribi, Kamel, Bolle, Delphine, Ghnaya, Habib, Sandu, Andrea, Besançon, Anne, Denizon, Nathalie, Truong, Catherine, Pineau-Vincent, Fabienne, de Materre, Alix Baugier
Published in Annals of hematology (01.04.2016)
Published in Annals of hematology (01.04.2016)
Get full text
Journal Article
Quadri‐lineage disease involving nodal B‐cell marginal zone lymphoma, high‐grade B‐cell lymphoma, Kaposi's syndrome, and acute myeloid leukemia
Laribi, Kamel, Ghnaya, Habib, Mention, Pierre‐Jean, Rousset, Hoel, Baugier de Materre, Alix, Pineau‐Vincent, Fabienne, Truong, Catherine, Bolle, Delphine
Published in Clinical case reports (01.01.2016)
Published in Clinical case reports (01.01.2016)
Get full text
Journal Article
Prognostic impact of elevated pretreatment serum ferritin in patients with high-risk MDS treated with azacitidine
Laribi, Kamel, Bolle, Delphine, Alani, Mustapha, Ghnaya, Habib, Le Bourdelles, Saga, Besançon, Anne, Farhi, Jonathan, Denizon, Nathalie, Baugier de Materre, Alix
Published in Experimental hematology (01.09.2018)
Published in Experimental hematology (01.09.2018)
Get full text
Journal Article
The bendamustine plus rituximab regimen is active against primary nodal marginal zone B‐cell lymphoma
Laribi, Kamel, Tempescul, Adrien, Ghnaya, Habib, Denizon, Nathalie, Besançon, Anne, Anghel, Andreea, Farhi, Jonathan, Truong, Catherine, Lemaire, Pierre, Poulain, Stephanie, Bolle, Delphine, Ianotto, Jean Christophe, Baugier de Materre, Alix
Published in Hematological oncology (01.12.2017)
Published in Hematological oncology (01.12.2017)
Get full text
Journal Article
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial
Chevret, Sylvie, Bouadma, Lila, Dupuis, Claire, Burdet, Charles, Timsit, Jean-François
Published in Annals of intensive care (27.08.2023)
Published in Annals of intensive care (27.08.2023)
Get full text
Journal Article
The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma: Bendamustine-rituximab in nodal MZL
Kamel, Laribi, Adrien, Tempescul, Habib, Ghnaya, Nathalie, Denizon, Anne, Besançon, Andreea, Anghel, Jonathan, Farhi, Catherine, Truong, Pierre, Lemaire, Stephanie, Poulain, Delphine, Bolle, Jean Christophe, Ianotto, Baugier de Materre, Alix
Published in Hematological oncology (01.07.2016)
Published in Hematological oncology (01.07.2016)
Get full text
Journal Article
Quadri-lineage disease involving nodal B-cell marginal zone lymphoma, high-grade B-cell lymphoma, Kaposi's syndrome, and acute myeloid leukemia
Laribi, Kamel, Ghnaya, Habib, Mention, Pierre-Jean, Rousset, Hoel, Baugier de Materre, Alix, Pineau-Vincent, Fabienne, Truong, Catherine, Bolle, Delphine
Published in Clinical case reports (01.01.2016)
Published in Clinical case reports (01.01.2016)
Get full text
Report